10th Annual Biotech in Europe Investor Forum
Start date: 29th September 2010
End date: 30th October 2010
Location: Radisson Blu Hotel, Zurich Airport
Now in its 10th year, the Annual Biotech in Europe Investor Forum is an exclusive and highly transactional forum for investing and partnering in the Biotech and Pharma industry.
The two-day conference programme will give you access to some of the leading players in the industry and will provide you with truly excellent networking opportunities as it boasts an online partnering system with 500 meeting slots available for all attendees to book before the event. With over 70 presenting companies and exciting plenary panel sessions from experts in their sector, the forum will provide a great opportunity to gain insight into partnering and investment trends in the Biotech and Pharma industry. We anticipate up to 400 delegates, and 150 companies are registered so far.
The partnering sessions feature presentations by representatives of the leading pharmaceutical and speciality pharmaceutical companies in the world. This includes; Bristol Myers Squibb, Merck, Merck Serono, Novartis, Novo Nordisk, Nycomed, Pfizer, and Roche.
- Pfizer returns worldwide rights to Celldex Thera’s rindopepimut brain tumor vaccine candidate
- India’s Natco challenges Celgene’s Revlimid patent in USA; new CFO named
- Roche plans job cuts, announcing Operational Excellence initiative
- US FDA makes label change on Pfizer’s Tygacil to reflect increased mortality risk
- Weighted average drug price cuts of 20% for over 4,000 drugs enforced in Greece as of today
